12/19/2007

The FDA has granted Escalon Medical Corp.'s Drew Scientific unit approval to market its D3 Hematology System, an automatic three-part differential hematology analyzer. The device should reach the market in the U.S. before the end of the year, Escalon said.

Full Story:
Reuters

Related Summaries